Published in Proc Natl Acad Sci U S A on April 07, 2009
International Union of Basic and Clinical Pharmacology. LXXVI. Current progress in the mammalian TRP ion channel family. Pharmacol Rev (2010) 2.66
Mutations in TRPV4 cause Charcot-Marie-Tooth disease type 2C. Nat Genet (2009) 2.32
Transient receptor potential channels as therapeutic targets. Nat Rev Drug Discov (2011) 2.25
Insights from cerebellar transcriptomic analysis into the pathogenesis of ataxia. JAMA Neurol (2014) 1.51
Progressive degeneration of dopaminergic neurons through TRP channel-induced cell death. J Neurosci (2014) 1.43
Transient receptor potential channelopathies. Pflugers Arch (2010) 1.40
Transient receptor potential (TRP) channels: a clinical perspective. Br J Pharmacol (2014) 1.25
Neuronal store-operated calcium entry pathway as a novel therapeutic target for Huntington's disease treatment. Chem Biol (2011) 1.25
Cerebellar modules operate at different frequencies. Elife (2014) 1.20
Ataxia and hypogonadism caused by the loss of ubiquitin ligase activity of the U box protein CHIP. Hum Mol Genet (2013) 1.17
Comparison of an expanded ataxia interactome with patient medical records reveals a relationship between macular degeneration and ataxia. Hum Mol Genet (2010) 1.16
Contactin-associated protein-2 antibodies in non-paraneoplastic cerebellar ataxia. J Neurol Neurosurg Psychiatry (2012) 1.16
Deranged calcium signaling in Purkinje cells and pathogenesis in spinocerebellar ataxia 2 (SCA2) and other ataxias. Cerebellum (2012) 1.12
Nna1 mediates Purkinje cell dendritic development via lysyl oxidase propeptide and NF-κB signaling. Neuron (2010) 1.06
PKC-dependent coupling of calcium permeation through transient receptor potential canonical 3 (TRPC3) to calcineurin signaling in HL-1 myocytes. Proc Natl Acad Sci U S A (2011) 1.00
NMDA receptor-dependent synaptic activation of TRPC channels in olfactory bulb granule cells. J Neurosci (2012) 0.98
TRPC channels and their implication in neurological diseases. CNS Neurol Disord Drug Targets (2010) 0.97
A self-limiting regulation of vasoconstrictor-activated TRPC3/C6/C7 channels coupled to PI(4,5)P₂-diacylglycerol signalling. J Physiol (2011) 0.94
The Moonwalker mouse: new insights into TRPC3 function, cerebellar development, and ataxia. Cerebellum (2014) 0.94
Developmental regulation of human embryonic stem cell-derived neurons by calcium entry via transient receptor potential channels. Stem Cells (2009) 0.93
Computational neurobiology is a useful tool in translational neurology: the example of ataxia. Front Neurosci (2015) 0.92
Light-dependent phosphorylation of the drosophila transient receptor potential ion channel. J Biol Chem (2010) 0.91
Early onset of ataxia in moonwalker mice is accompanied by complete ablation of type II unipolar brush cells and Purkinje cell dysfunction. J Neurosci (2013) 0.90
Consensus Paper: Cerebellar Development. Cerebellum (2016) 0.89
Cellular and circuit mechanisms underlying spinocerebellar ataxias. J Physiol (2016) 0.88
In vivo evidence that TRAF4 is required for central nervous system myelin homeostasis. PLoS One (2012) 0.88
Are Type 1 metabotropic glutamate receptors a viable therapeutic target for the treatment of cerebellar ataxia? J Physiol (2016) 0.88
Emerging roles of canonical TRP channels in neuronal function. Adv Exp Med Biol (2011) 0.87
Dendrite self-avoidance requires cell-autonomous slit/robo signaling in cerebellar purkinje cells. Neuron (2014) 0.86
mGluR1/TRPC3-mediated Synaptic Transmission and Calcium Signaling in Mammalian Central Neurons. Cold Spring Harb Perspect Biol (2011) 0.85
Candidate screening of the TRPC3 gene in cerebellar ataxia. Cerebellum (2011) 0.85
Modulation of canonical transient receptor potential channel 1 in the proliferation of oligodendrocyte precursor cells by the golli products of the myelin basic protein gene. J Neurosci (2011) 0.84
Do mutations in the murine ataxia gene TRPC3 cause cerebellar ataxia in humans? Mov Disord (2014) 0.84
The puzzling role of TRPC3 channels in motor coordination. Pflugers Arch (2009) 0.83
Disruption of metabotropic glutamate receptor signalling is a major defect at cerebellar parallel fibre-Purkinje cell synapses in staggerer mutant mice. J Physiol (2011) 0.83
Inhibition of diacylglycerol-sensitive TRPC channels by synthetic and natural steroids. PLoS One (2012) 0.83
The mutant Moonwalker TRPC3 channel links calcium signaling to lipid metabolism in the developing cerebellum. Hum Mol Genet (2015) 0.82
Conserved gating elements in TRPC4 and TRPC5 channels. J Biol Chem (2013) 0.82
The role for alterations in neuronal activity in the pathogenesis of polyglutamine repeat disorders. Neurotherapeutics (2014) 0.82
Induced pluripotent stem cell technology for modelling and therapy of cerebellar ataxia. Open Biol (2015) 0.82
TRPC3 ion channel subunit immunolocalization in the cochlea. Histochem Cell Biol (2009) 0.81
Post-Translational Modifications of TRP Channels. Cells (2014) 0.81
Ectopic cerebellar cell migration causes maldevelopment of Purkinje cells and abnormal motor behaviour in Cxcr4 null mice. PLoS One (2014) 0.81
Function and regulation of TRPP2 ion channel revealed by a gain-of-function mutant. Proc Natl Acad Sci U S A (2016) 0.80
New insights into behaviour using mouse ENU mutagenesis. Hum Mol Genet (2012) 0.80
Lack of kinase regulation of canonical transient receptor potential 3 (TRPC3) channel-dependent currents in cerebellar Purkinje cells. J Biol Chem (2011) 0.80
Contribution of plasma membrane Ca ATPase to cerebellar synapse function. World J Biol Chem (2010) 0.79
Lgr4 protein deficiency induces ataxia-like phenotype in mice and impairs long term depression at cerebellar parallel fiber-Purkinje cell synapses. J Biol Chem (2014) 0.77
mGluR1-mediated excitation of cerebellar GABAergic interneurons requires both G protein-dependent and Src-ERK1/2-dependent signaling pathways. PLoS One (2014) 0.76
Functional expression of calcium-permeable Canonical Transient Receptor Potential 4-containing channels promotes migration of medulloblastoma cells. J Physiol (2017) 0.76
Modeling Suggests TRPC3 Hydrogen Bonding and Not Phosphorylation Contributes to the Ataxia Phenotype of the Moonwalker Mouse. Biochemistry (2015) 0.75
Type-1 metabotropic glutamate receptor signaling in cerebellar Purkinje cells in health and disease. F1000Res (2017) 0.75
The PRRT2 knockout mouse recapitulates the neurological diseases associated with PRRT2 mutations. Neurobiol Dis (2016) 0.75
α-Synuclein Expression in the Mouse Cerebellum Is Restricted to VGluT1 Excitatory Terminals and Is Enriched in Unipolar Brush Cells. Cerebellum (2015) 0.75
TRPC1- and TRPC3-dependent Ca(2+) signaling in mouse cortical astrocytes affects injury-evoked astrogliosis in vivo. Glia (2017) 0.75
Dominant Mutations in GRM1 Cause Spinocerebellar Ataxia Type 44. Am J Hum Genet (2017) 0.75
A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration. Cell (2006) 8.61
TRP channels. Annu Rev Biochem (2007) 8.09
An introduction to TRP channels. Annu Rev Physiol (2006) 7.52
Deficient cerebellar long-term depression and impaired motor learning in mGluR1 mutant mice. Cell (1994) 3.35
RORalpha-mediated Purkinje cell development determines disease severity in adult SCA1 mice. Cell (2006) 2.80
Polyglutamine expansion down-regulates specific neuronal genes before pathologic changes in SCA1. Nat Neurosci (2000) 2.72
TRPC channels promote cerebellar granule neuron survival. Nat Neurosci (2007) 2.47
Activation of the TRPC1 cation channel by metabotropic glutamate receptor mGluR1. Nature (2003) 2.31
TRPC3 channels are required for synaptic transmission and motor coordination. Neuron (2008) 2.30
Formation of novel TRPC channels by complex subunit interactions in embryonic brain. J Biol Chem (2003) 2.29
Regulation of canonical transient receptor potential (TRPC) channel function by diacylglycerol and protein kinase C. J Biol Chem (2003) 2.26
mGluR1 in cerebellar Purkinje cells essential for long-term depression, synapse elimination, and motor coordination. Science (2000) 2.09
Purkinje cell expression of a mutant allele of SCA1 in transgenic mice leads to disparate effects on motor behaviors, followed by a progressive cerebellar dysfunction and histological alterations. J Neurosci (1997) 1.99
mRNA distribution analysis of human TRPC family in CNS and peripheral tissues. Brain Res Mol Brain Res (2002) 1.98
Molecular pathogenesis of spinocerebellar ataxias. Brain (2006) 1.59
The molecular organization of cerebellar long-term depression. Nat Rev Neurosci (2002) 1.57
VAMP2-dependent exocytosis regulates plasma membrane insertion of TRPC3 channels and contributes to agonist-stimulated Ca2+ influx. Mol Cell (2004) 1.49
Pathways to motor incoordination: the inherited ataxias. Nat Rev Neurosci (2004) 1.43
Negative regulation of TRPC3 channels by protein kinase C-mediated phosphorylation of serine 712. Mol Pharmacol (2004) 1.42
TRP channel and cardiovascular disease. Pharmacol Ther (2008) 1.42
A mutation in Af4 is predicted to cause cerebellar ataxia and cataracts in the robotic mouse. J Neurosci (2003) 1.29
Characterization of the c-Jun N-terminal kinase-BimEL signaling pathway in neuronal apoptosis. J Neurosci (2004) 1.24
Cellular and molecular control of dendritic growth and development of cerebellar Purkinje cells. Prog Histochem Cytochem (2004) 1.14
Implementation of a large-scale ENU mutagenesis program: towards increasing the mouse mutant resource. Mamm Genome (2000) 1.11
An introduction on TRP channels. Handb Exp Pharmacol (2007) 1.09
Enzymological analysis of mutant protein kinase Cgamma causing spinocerebellar ataxia type 14 and dysfunction in Ca2+ homeostasis. J Biol Chem (2008) 1.06
Alzheimer's disease: neurodevelopment converges with neurodegeneration. Cell (2000) 1.05
Altered dendritic development of cerebellar Purkinje cells in slice cultures from protein kinase Cgamma-deficient mice. Neuroscience (2002) 1.04
Changes in TRPC channel expression during postnatal development of cerebellar neurons. Cell Calcium (2006) 1.00
Activation of class I metabotropic glutamate receptors limits dendritic growth of Purkinje cells in organotypic slice cultures. Eur J Neurosci (2006) 0.95
Developmental changes in the localisation of the mGluR1alpha subtype of metabotropic glutamate receptors in Purkinje cells. Neuroscience (2001) 0.92
Recent advances in degenerative ataxias. Curr Opin Neurol (2000) 0.88
Behavioural characterisation of the robotic mouse mutant. Behav Brain Res (2007) 0.87
TRPC3: a multifunctional, pore-forming signalling molecule. Handb Exp Pharmacol (2007) 0.85
The highly heterogeneous spinocerebellar ataxias: from genes to targets for therapeutic intervention. Cerebellum (2008) 0.84
Out FOXing Parkinson disease: where development meets neurodegeneration. PLoS Biol (2007) 0.81
Evolution and functions of long noncoding RNAs. Cell (2009) 17.54
Mouse genomic variation and its effect on phenotypes and gene regulation. Nature (2011) 10.66
A genome-wide investigation of SNPs and CNVs in schizophrenia. PLoS Genet (2009) 5.01
A functional genetic link between distinct developmental language disorders. N Engl J Med (2008) 4.99
Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol Rev (2002) 4.80
Mutations in dynein link motor neuron degeneration to defects in retrograde transport. Science (2003) 4.40
Overexpression of Fto leads to increased food intake and results in obesity. Nat Genet (2010) 4.37
Functional multivesicular bodies are required for autophagic clearance of protein aggregates associated with neurodegenerative disease. J Cell Biol (2007) 4.30
Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nat Genet (2005) 4.21
Species-specific transcription in mice carrying human chromosome 21. Science (2008) 4.03
An aneuploid mouse strain carrying human chromosome 21 with Down syndrome phenotypes. Science (2005) 3.61
Balancing selection at the prion protein gene consistent with prehistoric kurulike epidemics. Science (2003) 3.59
SCFFbxl3 controls the oscillation of the circadian clock by directing the degradation of cryptochrome proteins. Science (2007) 3.59
The mixed-lineage leukemia fusion partner AF4 stimulates RNA polymerase II transcriptional elongation and mediates coordinated chromatin remodeling. Hum Mol Genet (2006) 3.39
Genomic and transcriptional co-localization of protein-coding and long non-coding RNA pairs in the developing brain. PLoS Genet (2009) 3.38
Mutation of Celsr1 disrupts planar polarity of inner ear hair cells and causes severe neural tube defects in the mouse. Curr Biol (2003) 3.31
Mutations in alpha-tubulin cause abnormal neuronal migration in mice and lissencephaly in humans. Cell (2007) 3.06
The after-hours mutant reveals a role for Fbxl3 in determining mammalian circadian period. Science (2007) 3.05
Genetic analysis of the cytoplasmic dynein subunit families. PLoS Genet (2006) 2.35
Pharmacological strategies for muscular dystrophy. Nat Rev Drug Discov (2003) 2.32
FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration. Acta Neuropathol (2010) 2.30
Impaired synaptic plasticity and motor learning in mice with a point mutation implicated in human speech deficits. Curr Biol (2008) 2.27
Long noncoding RNA genes: conservation of sequence and brain expression among diverse amniotes. Genome Biol (2010) 2.20
The origins and uses of mouse outbred stocks. Nat Genet (2005) 2.19
Deletion at ITPR1 underlies ataxia in mice and spinocerebellar ataxia 15 in humans. PLoS Genet (2007) 2.09
C9orf72 hexanucleotide repeat associated with amyotrophic lateral sclerosis and frontotemporal dementia forms RNA G-quadruplexes. Sci Rep (2012) 2.09
A transcriptomic atlas of mouse neocortical layers. Neuron (2011) 2.08
Current status of pharmaceutical and genetic therapeutic approaches to treat DMD. Mol Ther (2011) 2.06
Hsp72 preserves muscle function and slows progression of severe muscular dystrophy. Nature (2012) 2.04
High-throughput analysis of promoter occupancy reveals direct neural targets of FOXP2, a gene mutated in speech and language disorders. Am J Hum Genet (2007) 2.01
A mutation in dynein rescues axonal transport defects and extends the life span of ALS mice. J Cell Biol (2005) 2.01
Functional genetic analysis of mutations implicated in a human speech and language disorder. Hum Mol Genet (2006) 1.85
Down syndrome--recent progress and future prospects. Hum Mol Genet (2009) 1.85
Neuromuscular defects in a Drosophila survival motor neuron gene mutant. Hum Mol Genet (2003) 1.85
Alternative splicing events are a late feature of pathology in a mouse model of spinal muscular atrophy. PLoS Genet (2009) 1.76
Reliability, robustness, and reproducibility in mouse behavioral phenotyping: a cross-laboratory study. Physiol Genomics (2008) 1.76
Cytoplasmic dynein nomenclature. J Cell Biol (2005) 1.71
Therapy for Duchenne muscular dystrophy: renewed optimism from genetic approaches. Nat Rev Genet (2013) 1.70
Tumour angiogenesis is reduced in the Tc1 mouse model of Down's syndrome. Nature (2010) 1.70
Novel markers reveal subpopulations of subplate neurons in the murine cerebral cortex. Cereb Cortex (2008) 1.67
Duchenne muscular dystrophy and dystrophin: pathogenesis and opportunities for treatment. EMBO Rep (2004) 1.66
Foxp2 regulates gene networks implicated in neurite outgrowth in the developing brain. PLoS Genet (2011) 1.56
Mutations in Rab3a alter circadian period and homeostatic response to sleep loss in the mouse. Nat Genet (2002) 1.48
DYRK1A-dosage imbalance perturbs NRSF/REST levels, deregulating pluripotency and embryonic stem cell fate in Down syndrome. Am J Hum Genet (2008) 1.45
TDP-43 is a culprit in human neurodegeneration, and not just an innocent bystander. Mamm Genome (2008) 1.44
Utrophin binds laterally along actin filaments and can couple costameric actin with sarcolemma when overexpressed in dystrophin-deficient muscle. Mol Biol Cell (2002) 1.44
Homozygosity for the C9orf72 GGGGCC repeat expansion in frontotemporal dementia. Acta Neuropathol (2013) 1.41
Novel ENU-induced eye mutations in the mouse: models for human eye disease. Hum Mol Genet (2002) 1.41
When clocks go bad: neurobehavioural consequences of disrupted circadian timing. PLoS Genet (2008) 1.41
Plectin 1f scaffolding at the sarcolemma of dystrophic (mdx) muscle fibers through multiple interactions with beta-dystroglycan. J Cell Biol (2007) 1.39
Disruption of endocytic trafficking in frontotemporal dementia with CHMP2B mutations. Hum Mol Genet (2010) 1.35
Expansion of revertant fibers in dystrophic mdx muscles reflects activity of muscle precursor cells and serves as an index of muscle regeneration. J Cell Sci (2006) 1.34
Prevention of dystrophic pathology in severely affected dystrophin/utrophin-deficient mice by morpholino-oligomer-mediated exon-skipping. Mol Ther (2009) 1.31
Identification of genetic loci affecting mouse-adapted bovine spongiform encephalopathy incubation time in mice. Neurogenetics (2002) 1.31
Therapeutic approaches to muscular dystrophy. Hum Mol Genet (2011) 1.30
A mutation in Af4 is predicted to cause cerebellar ataxia and cataracts in the robotic mouse. J Neurosci (2003) 1.29
Daily treatment with SMTC1100, a novel small molecule utrophin upregulator, dramatically reduces the dystrophic symptoms in the mdx mouse. PLoS One (2011) 1.29
Sexual selection and the adaptive evolution of mammalian ejaculate proteins. Mol Biol Evol (2007) 1.28
Down syndrome: searching for the genetic culprits. Dis Model Mech (2011) 1.28
Identification and characterization of murine SCARA5, a novel class A scavenger receptor that is expressed by populations of epithelial cells. J Biol Chem (2006) 1.25
Superoxide dismutase 1 and tgSOD1 mouse spinal cord seed fibrils, suggesting a propagative cell death mechanism in amyotrophic lateral sclerosis. PLoS One (2010) 1.25
Novel phenotypes identified by plasma biochemical screening in the mouse. Mamm Genome (2002) 1.22
An ENU-induced mutation in mouse glycyl-tRNA synthetase (GARS) causes peripheral sensory and motor phenotypes creating a model of Charcot-Marie-Tooth type 2D peripheral neuropathy. Dis Model Mech (2009) 1.22
A dominant mutation in Snap25 causes impaired vesicle trafficking, sensorimotor gating, and ataxia in the blind-drunk mouse. Proc Natl Acad Sci U S A (2007) 1.22
A mutation in the small heat-shock protein HSPB1 leading to distal hereditary motor neuronopathy disrupts neurofilament assembly and the axonal transport of specific cellular cargoes. Hum Mol Genet (2005) 1.21
Diaphragm rescue alone prevents heart dysfunction in dystrophic mice. Hum Mol Genet (2010) 1.19
The long non-coding RNA Paupar regulates the expression of both local and distal genes. EMBO J (2014) 1.19
Genomically humanized mice: technologies and promises. Nat Rev Genet (2011) 1.18
Preservation of long-term memory and synaptic plasticity despite short-term impairments in the Tc1 mouse model of Down syndrome. Learn Mem (2008) 1.18
SOD1 and TDP-43 animal models of amyotrophic lateral sclerosis: recent advances in understanding disease toward the development of clinical treatments. Mamm Genome (2011) 1.17
Rodent models of amyotrophic lateral sclerosis. Biochim Biophys Acta (2013) 1.17
Translating the genomics revolution: the need for an international gene therapy consortium for monogenic diseases. Mol Ther (2013) 1.16
Sarcolemmal nNOS anchoring reveals a qualitative difference between dystrophin and utrophin. J Cell Sci (2010) 1.14
Gene-environment interactions differentially affect mouse strain behavioral parameters. Mamm Genome (2006) 1.14
Down's syndrome-like cardiac developmental defects in embryos of the transchromosomic Tc1 mouse. Cardiovasc Res (2010) 1.13
Oxr1 is essential for protection against oxidative stress-induced neurodegeneration. PLoS Genet (2011) 1.13
ZZ domain is essentially required for the physiological binding of dystrophin and utrophin to beta-dystroglycan. Hum Mol Genet (2004) 1.12
Massively parallel sequencing reveals the complex structure of an irradiated human chromosome on a mouse background in the Tc1 model of Down syndrome. PLoS One (2013) 1.10
Rescue of severely affected dystrophin/utrophin-deficient mice through scAAV-U7snRNA-mediated exon skipping. Hum Mol Genet (2012) 1.10
Identification of valid housekeeping genes for quantitative RT-PCR analysis of cardiosphere-derived cells preconditioned under hypoxia or with prolyl-4-hydroxylase inhibitors. Mol Biol Rep (2011) 1.10
Impairments in motor coordination without major changes in cerebellar plasticity in the Tc1 mouse model of Down syndrome. Hum Mol Genet (2009) 1.09
Cytoplasmic dynein heavy chain: the servant of many masters. Trends Neurosci (2013) 1.09
The Pathogenesis and Therapy of Muscular Dystrophies. Annu Rev Genomics Hum Genet (2015) 1.08
Perturbed hematopoiesis in the Tc1 mouse model of Down syndrome. Blood (2010) 1.08
Deletion of smn-1, the Caenorhabditis elegans ortholog of the spinal muscular atrophy gene, results in locomotor dysfunction and reduced lifespan. Hum Mol Genet (2008) 1.08
Brain, know thy transcriptome, know thyself. Neuron (2012) 1.08
Evidence for a dominant-negative effect in ACTA1 nemaline myopathy caused by abnormal folding, aggregation and altered polymerization of mutant actin isoforms. Hum Mol Genet (2004) 1.08
Mouse models of dominant ACTA1 disease recapitulate human disease and provide insight into therapies. Brain (2011) 1.08